HCPConnect

For HCPs Only
Recent Clinical Updates
Loading latest clinical updates

Clinical Intelligence.

Synchronized research and peer-reviewed trials for modern professionals.

Clinical Coverage

Search drug updates and clinical coverage.

6 loaded
Endocrinology

FDA Approves Tzield for Type 1 Diabetes: Delays Onset in Pediatric Patients

Tzield (teplizumab) delays onset of Stage 3 Type 1 diabetes in pediatric patients aged 8 to 17 years.

Jun 15|4 min read|Dr. Amit Desai
Rheumatoid Arthritis

FDA Approves First Biosimilar to Actemra: Tofidence for Rheumatoid Arthritis

FDA approves Tofidence for rheumatoid arthritis, the first biosimilar to Actemra, enhancing access to effective therapies.

Jun 14|4 min read|Editorial Team
Pulmonology

Asthma Triple Inhaler Therapy: Patient Selection Criteria for Trimbow, Trelegy, and Breztri

Asthma triple inhaler therapy: Patient selection criteria for Trimbow, Trelegy, and Breztri in severe asthma management.

Jun 14|4 min read|Dr. Nikhil Chatterjee
Rheumatology

FDA Approves Immgolis for Rheumatoid Arthritis and Ulcerative Colitis: First Interchangeable Biosimilar to Simponi

Immgolis (golimumab-sldi) approved for rheumatoid arthritis and ulcerative colitis: first interchangeable biosimilar to Simponi.

Jun 14|4 min read|Dr. Deepak Nair
Oncology

FDA Panel Votes Against Camizestrant for ESR1-Mutated Breast Cancer

Camizestrant: FDA panel votes against approval for ESR1-mutated breast cancer treatment.

Jun 14|4 min read|Dr. Meera Pillai
Dermatology

FDA Approves Bimekizumab for Moderate to Severe Plaque Psoriasis: 75% sPGA Response in BE VIVID Trial

Bimekizumab (Bimzelx) approved for moderate to severe plaque psoriasis: 75% sPGA response in BE VIVID trial.

Jun 14|4 min read|Dr. Divya Agarwal